Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid + Chemotherapy in Refractory/Relapsing SCLC
NCT00759824Phase 2Completed
- Sponsor
- European Lung Cancer Working Party
- Start
- Sep 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in small cell lung cancer (SCLC), sponsored by European Lung Cancer Working Party. Started Sep 2008; status: completed.
02
Drugs
valproic acid
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00759824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759824.